Isoliquiritigenin suppresses human T Lymphocyte activation via covalently binding cysteine 46 of IκB kinase.
Yan F, Yang F, Wang R, Yao XJ, Bai L, Zeng X, Huang J, Wong VKW, Lam CWK, Zhou H, Su X, Liu J, Li T, Liu L.
Yan F, et al. Among authors: huang j.
Oncotarget. 2017 May 23;8(21):34223-34235. doi: 10.18632/oncotarget.11934.
Oncotarget. 2017.
PMID: 27626700
Free PMC article.